Rituximab HY-P9913 from MedChemExpress

Product Specs
ItemRituximab
CompanyMedChemExpress
Price $280.00Supplier Page View Company Product Page
Catalog NumberHY-P9913
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.85%
Research AreaInflammation/Immunology; Cancer
TypeChemical
Molecular Weight144544.44
Quantity1 mg
Molecule NameRituximab

Add to Compare List

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) Towards an Analytical Procedure Control Strategy for the Capillary Zone Electrophoresis Method for Monoclonal Antibodies: Alternatives for ε‐Aminocaproic Acid and TriethylenetetramineELECTROPHORESISSeptember 23, 2025Joanne Baxter, Lori Fitton, Cari E S Sänger ‐ van de Griendat the extremities of the range, Infliximab (pI 7.6, HY‐P9970 MedChemExpress) and Rituximab (pI 9.4, HY‐P9913 MedChemExpress). The mAbs were diluted to 1 mg/mL with ultrapure water, and aliquots were stored at

(2) Inhibition of HBV Replication by a Fully Humanized Neutralizing Antibody In Vivo and In VitroActa NaturaeJanuary 1, 2025Zhipeng Zhang, Yanqin Ma, Yan He, Dong Wang, Huaien Song, Kun Yue, Xiaomei Zhangdensity of 4 × 105 cells/ml. The antibodies, including positive control Rituximab (MedChemExpress, cat. # HY-P9913, USA) and negative control IgG1 (Genenode, cat. # 91001B, China), were then prepared at concentrations

(3) Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinomaFrontiers in immunologyJanuary 1, 2024Sakata T, Yoshio S, Yamazoe T, Mori T, Kakazu E, Aoki Y, Aoyanagi N, Okamoto T, Ito T, Toyoda H, et al.ng/mL) (200-02; Thermo Fisher Scientific) was added before the cytotoxicity assay. Rituximab (10 μg/mL) (HY-P9913; MedChemExpress, Monmouth Junction, NJ) was added before the ADCC assay. Before the functional recovery

(4) In vitro effects of rituximab on the proliferation, activation and differentiation of human B cellsAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsFebruary 1, 2012Kamburova EG, Koenen HJ, Boon L, Hilbrands LB, Joosten I.

(5) In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomasBloodFebruary 1, 2003Manches O, Lui G, Chaperot L, Gressin R, Molens JP, Jacob MC, Sotto JJ, Leroux D, Bensa JC, Plumas J.

(6) The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis inductionBloodFebruary 1, 2002Byrd JC, Kitada S, Flinn IW, Aron JL, Pearson M, Lucas D, Reed JC.

Be the First to Write a Review!

Rituximab from MedChemExpress

Description

MedChemExpress

Citations (6)

Reviews

Rituximab from MedChemExpress

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map